The Wait is Over. Or Is It? DEA’s Proposed Rules Around Telemedicine Prescribing: Initial Impressions and Key Takeaways
Health Law Advisor
MARCH 7, 2023
In the proposed rules regarding buprenorphine DEA says that a practitioner must be registered in the state where he/she is located, however, DEA does not address this issue in its proposed rules governing the special registration requirements generally. Provider Education and Understanding About New Prescribing and Recordkeeping Requirements.
Let's personalize your content